ManufacturingWith a $70 million expansion in Massachusetts, AbbVie plans...
Manufacturing

With a $70 million expansion in Massachusetts, AbbVie plans the next phase of its US investment adventure

Editotial Team
By Editotial Team

-

777
0

No content provided.

e8ca33a26f7037921e92de08cb2a519d8f9a37c9966383abf07edbf18b55cb25?s=150&d=mp&r=g
+ posts
Previous article
Rocket abandons its attempt to obtain FDA approval for bone marrow gene therapy
Next article
Aerska Launches with $21 Million to Develop RNAi Medicines for Neurological Diseases
Editotial Team
Editotial Team
Editotial Team
Editotial Team
Editotial Team
Editotial Team
Editotial Team
Editotial Team

Latest news

Clinical

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Aligos Therapeutics has reached an agreement with hepatology-focused biopharma company Amoytop, obtaining $25 million in upfront cash in exchange...
Commercial

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in a transaction valued at up to $1.1 billion, combining cash...
Commercial

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Eli Lilly has agreed to acquire CrossBridge Bio, a Houston-based biotechnology company focused on cancer treatments, as part of...

Must read

Commercial

Commercial Excellence Summit Brings Together Leading Minds to Solve Critical Commercial Problems

This week is set to be a pivotal one...
Commercial

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...
Editorial Team -
Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -
Manufacturing

Viatris to Cut 10% of Workforce Following Strategic Review and Reports Fire at India Plant

Viatris has outlined plans to reduce its global workforce...
Editorial Team -
Manufacturing

Novartis Names Texas as Site For RadioPharma Production Facility

Novartis is moving quickly to outline how radiopharmaceutical manufacturing...
Editorial Team -